Genetics and geoepidemiology of primary biliary cirrhosis: Following the footprints to disease etiology

Seminars in Liver Disease

Volumn 25, Issue 3, 2005, Pages 265-280

  Selmi, Carlo ^b,c   Invernizzi, Pietro ^b   Zuin, Massimo ^b   Podda, Mauro ^b   Gershwin, M Eric ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimitochondrial antibodies; Autoimmune cholangitis; Geographical pattern; Multigene

Indexed keywords

MITOCHONDRION ANTIBODY;

AUTOIMMUNE DISEASE; BILE DUCT DISEASE; EPIDEMIOLOGICAL DATA; EUROPE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC ORIGIN; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MONOZYGOTIC TWINS; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UNITED STATES;

EUROPE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INCIDENCE; LIVER CIRRHOSIS, BILIARY; MAJOR HISTOCOMPATIBILITY COMPLEX; RISK FACTORS; SIBLINGS; UNITED STATES;

EID: 24344502234     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916319     Document Type: Review

References (125)

1. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003;362:53-61
2. Prince M, Chetwynd A, Newman W, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 2002;123:1044-1051
3. Gluud C, Christensen E. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev 2002; CD000551
4. MacQuillan GC, Neuberger J. Liver transplantation for primary biliary cirrhosis. Clin Liver Dis 2003;7:941-956 ix.
5. Risch N. Searching for genes in complex diseases: lessons from systemic lupus erythematosus. J Clin Invest 2000;105: 1503-1506
6. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-99
7. Becker KG, Simon RM, Bailey-Wilson JE, et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998;95:9979-9984
8. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61
9. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-1238
10. Ichiki Y, Shimoda S, Ishibashi H, Gershwin ME. Is primary biliary cirrhosis a model autoimmune disease? Autoimmun Rev 2004;3:331-336
11. Donaldson P, Agarwal K, Craggs A, et al. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 2001;48:397-402
12. Selmi C, Mayo MJ, Bach N, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004;127:485-492
13. Greco L, Romino R, Coto I, et al. The first large population based twin study of coeliac disease. Gut 2002;50:624-628
14. Selmi C, Invernizzi P, Miozzo M, et al. Primary biliary cirrhosis: does X mark the spot? Autoimmun Rev 2004;3: 493-499
15. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001;2:777-780
16. Invernizzi P, Miozzo M, Battezzati PM, et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004;363:533-535
17. Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995;36:615-617
18. Hamlyn AN, Macklon AF, James O. Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality. Gut 1983;24:940-945
19. Myszor M, James OF. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease? Q J Med 1990;75:377-385
20. James OF, Bhopal R, Howel D, et al. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 1999;30:390-394
21. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994;20:698-701
22. Danielsson A, Boqvist L, Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 1990;11:458-464
23. Floreani A, Naccarato R, Chiaramonte M. Prevalence of familial disease in primary biliary cirrhosis in Italy. J Hepatol 1997;26:737-738
24. Tsuji K, Watanabe Y, Van De Water J, et al. Familial primary biliary cirrhosis in Hiroshima. J Autoimmun 1999; 13:171-178
25. Kim WR, Lindor KD, Locke GR III, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000;119:1631-1636
26. Jones DE, Watt FE, Metcalf JV, et al. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999;30:402-407
27. Olafsson S, Gudjonsson H, Selmi C, et al. Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am J Gastroenterol 2004;99:2143-2146
28. Feizi T, Naccarato R, Sherlock S, Doniach D. Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol 1972;10:609-622
29. Galbraith RM, Smith M, Mackenzie RM, et al. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med 1974;290:63-69
30. Watt FE, James OF, Jones DE. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 2004;97:397-406
31. Bittencourt PL, Farias AQ, Abrantes-Lemos CP, et al. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2004;19:873-878
32. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43:30-37
33. Chohan MR. Primary biliary cirrhosis in twin sisters. Gut 1973;14:213-214
34. Kaplan MM, Rabson AR, Lee YM, et al. Discordant occurrence of primary biliary cirrhosis in monozygotic twins. N Engl J Med 1994;331:951
35. Freeman HJ. Primary biliary cirrhosis in genetically identical twins. Gastroenterology 2004;127:1645
36. Selmi C, Gershwin ME. Reply to Dr. Freeman. Gastroenterology 2004;127:1645
37. Selmi C, Gershwin ME. Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol 2004;16:406-410
38. Kita H, He XS, Gershwin ME. Autoimmunity and environmental factors in the pathogenesis of primary biliary cirrhosis. Ann Med 2004;36:72-80
39. McCluskey J, Peh CA. The human leucocyte antigens and clinical medicine: an overview. Rev Immunogenet 1999;1: 3-20
40. Carson DA. Genetic factors in the etiology and pathogenesis of autoimmunity. FASEB J 1992;6:2800-2805
41. Ercilla G, Parés A, Arriaga F, et al. Primary biliary cirrhosis associated with DLA-DRw3. Tissue Antigens 1979;14:449-452
42. Miyamori H, Kato Y, Kobayashi K, Hattori N. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion 1983;26:213-217
43. Onishi S, Sakamaki T, Maeda T, et al. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol 1994;21: 1053-1060
44. Bassendine MF, Dewar PJ, James OF. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut 1985;26: 625-628
45. Briggs DC, Donaldson PT, Hayes P, et al. A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC). Tissue Antigens 1987;29:141-145
46. Manns MP, Bremm A, Schneider PM, et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991;101:1367-1373
47. Morling N, Dalhoff K, Fugger L, et al. DNA polymorphism of HLA class II genes in primary biliary cirrhosis. Immunogenetics 1992;35:112-116
48. Invernizzi P, Battezzati PM, Crosignani A, et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 2003;38:401-406
49. Gores GJ, Moore SB, Fisher LD, et al. Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology 1987;7:889-892
50. Begovich AB, Klitz W, Moonsamy PV, et al. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 1994; 43:71-77
51. Wassmuth R, Depner F, Danielsson A, et al. HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens 2002;59:381-387
52. Zhang L, Weetman AP, Bassendine M, Oliveira DB. Major histocompatibility complex class-II alleles in primary biliary cirrhosis. Scand J Immunol 1994;39:104-106
53. Bittencourt PL, Palacios SA, Farias AQ, et al. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2003;18:1061-1066
54. Mella JG, Roschmann E, Maier KP, Volk BA. Association of primary biliary cirrhosis with the allele HLA-DPB1*0301 in a German population. Hepatology 1995;21:398-402
55. Seki T, Kiyosawa K, Ota M, et al. Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients. Hepatology 1993;18:73-78
56. Gregory WL, Daly AK, Dunn AN, et al. Analysis of HLA-class-II-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis. Q J Med 1994;87:237-244
57. Donaldson PT. TNF gene polymorphisms in primary biliary cirrhosis: a critical appraisal. J Hepatol 1999;31:366-368
58. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353
59. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199
60. Kroeger KM, Carville KS, Abraham LJ. The - 308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997;34:391-399
61. Wu WS, McClain KL. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res 1997;17:631-635
62. Gordon MA, Oppenheim E, Camp NJ, et al. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region [see comments]. J Hepatol 1999;31:242-247
63. Tanaka A, Quaranta S, Mattalia A, et al. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis. J Hepatol 1999;30:826-829
64. Jones DE, Watt FE, Grove J, et al. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis [see comments]. J Hepatol 1999;30:232-236
65. Dickson ER, Grambsch PM, Fleming TR, et al. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989;10:1-7
66. Bathgate AJ, Pravica V, Perrey C, et al. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol 2000;12:1329-1333
67. Fan LY, Zhong RQ, Tu XQ, et al. Genetic association of tumor necrosis factor (TNF)-alpha polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population. Zhonghua Gan Zang Bing Za Zhi 2004;12:160-162
68. Jazrawi SF, Zaman A, Muhammad Z, et al. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs. Liver Transpl 2003;9:377-382
69. Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928-933
70. Agarwal K, Jones DE, Daly AK, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis, [in process citation]. J Hepatol 2000;32:538-541
71. Fan LY, Tu XQ, Cheng QB, et al. Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J Gastroenterol 2004;10: 3056-3059
72. Kershenobich D, Rojkind M, Quiroga A, Alcocer-Varela J. Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis. Hepatology 1990;11:205-209
73. Lakatos LP, Bajnok E, Hegedus D, et al. Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2002;14:733-740
74. Fan LY, Zhu Y, Zhong RQ, et al. Genetic association between interleukins gene polymorphisms with primary biliary cirrhosis in Chinese population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2004;26:505-509
75. Matsushita M, Tanaka A, Kikuchi K, et al. Association of single nucleotide polymorphisms of the interleukin-10 promoter gene and susceptibility to primary biliary cirrhosis: immunogenetic differences in Italian and Japanese patients. Autoimmunity 2002;35:531-536
76. Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002;35: 126-131
77. Halmos B, Szalay F, Cserniczky T, et al. Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population. Dig Dis Sci 2000;45:1091-1095
78. Fan LY, Zhong RQ, Tu XQ, et al. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune liver diseases on Chinese. Zhonghua Yi Xue Za Zhi 2003;83:1852-1855
79. Springer JE, Cole DE, Rubin LA, et al. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 2000;118:145-151
80. Pares A, Guanabens N, Alvarez L, et al. Collagen type I alpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 2001;33: 554-560
81. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 2004;39:476-483
82. Long SA, Quan C, Van de Water J, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001;167:2956-2963
83. Kimura Y, Selmi C, Leung PS, et al. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis. Hepatology 2005; 41:55-63
84. Pauli-Magnus C, Kerb R, Fattinger K, et al. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 2004;39:779-791
85. Pauli-Magnus C, Lang T, Meier Y, et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 2004;14:91-102
86. Ku NO, Darling JM, Krams SM, et al. Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc Natl Acad Sci USA 2003;100: 6063-6068
87. Higuchi M, Horiuchi T, Kojima T, et al. Analysis of CD40 ligand gene mutations in patients with primary biliary cirrhosis. Scand J Clin Lab Invest 1998;58:429-432
88. Corpechot C, Poupon R. Promoter polymorphism of the CD14 endotoxin receptor gene and primary biliary cirrhosis. Hepatology 2002;35:242-243
89. Selmi C, Zuin M, Biondi ML, et al. Genetic variants of endothelial nitric oxide synthase in patients with primary biliary cirrhosis: association with disease severity. J Gastroenterol Hepatol 2003;18:1150-1155
90. Kikuchi K, Tanaka A, Miyakawa H, et al. Eta-1/osteopontin genetic polymorphism and primary biliary cirrhosis. Hepatol Res 2003;26:87-90
91. Selmi C, Invernizzi P, Tripputi P, et al. T-cell receptor polymorphism in primary biliary cirrhosis. Ann Ital Med Int 2003;18:149-153
92. Lakatos PL, Bajnok E, Tornai I, et al. Insulin-like growth factor I gene microsatellite repeat, collagen type Ialpha1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2004;16:753-759
93. Ranke MB, Saenger P. Turner's syndrome. Lancet 2001;358: 309-314
94. Davis CJ, Davison RM, Payne NN, et al. Female sex preponderance for idiopathic familial premature ovarian failure suggests an X chromosome defect: opinion. Hum Reprod 2000;15:2418-2422
95. Kaplan MM, Bianchi DW. Primary biliary cirrhosis: for want of an X chromosome? Lancet 2004;363:505-506
96. Guttenbach M, Koschorz B, Bernthaler U, et al. Sex chromosome loss and aging: in situ hybridization studies on human interphase nuclei. Am J Hum Genet 1995;57: 1143-1150
97. Lambert N, Nelson JL. Microchimerism in autoimmune disease: more questions than answers? Autoimmun Rev 2003;2:133-139
98. Fanning PA, Jonsson JR, Clouston AD, et al. Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J Hepatol 2000;33:690-695
99. Tanaka A, Lindor K, Gish R, et al. Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis. Hepatology 1999;30:833-838
100. Invernizzi P, De Andreis C, Sirchia SM, et al. Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol 2000;122:418-422
101. Oertelt S, Selmi C, Invernizzi P, et al. Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmun Rev. In press
102. Hinds DA, Stuve LL, Nilsen GB, et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005;307:1072-1079
103. Abu-Mouch S, Selmi C, Benson GD, et al. Geographic clusters of primary biliary cirrhosis. Clin Dev Immunol 2003;10:127-131
104. Arbour L, Field L, Ross P, et al. The mystery of primary biliary cirrhosis in British Columbia's First Nations people. Int J Circumpolar Health 2004;63(suppl 2):185-188
105. Ala A, Ahmado I, Stanca C, et al. The prevalence of primary biliary cirrhosis is increased near toxic waste sites in New York City. Hepatology 2004;40:205A
106. Metcalf JV, Bhopal RS, Gray J, et al. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol 1997;26: 830-836
107. Triger DR. Primary biliary cirrhosis: an epidemiological study. BMJ 1980;281:772-775
108. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335:1570-1580
109. Hislop WS, Main G, Robertson AJ. Primary biliary cirrhosis: experience in a non-referral centre. Lancet 1981; 2:144
110. Goudie B, MacFarlane G, Boyle P. Epidemiology of antimitichondrial antibody seropositivity and primary biliary cirrhosis in west of Scotland. Gut 1987;28:A1346
111. Eriksson S, Lindgren S. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. Scand J Gastroenterol 1984;19:971-976
112. Lofgren J, Jarnerot G, Danielsson D, Hemdal I. Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden. Scand J Gastroenterol 1985;20:647-650
113. Remmel T, Remmel H, Uibo R, Salupere V. Primary biliary cirrhosis in Estonia. With special reference to incidence, prevalence, clinical features, and outcome. Scand J Gastroenterol 1995;30:367-371
114. Triger DR, Berg PA, Rodes J. Epidemiology of primary biliary cirrhosis. Liver 1984;4:195-200
115. Shibata M, Onozuka Y, Morizane T, et al. Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanagawa prefecture. J Gastroenterol 2004;39: 255-259
116. Watson RG, Angus PW, Dewar M, et al. Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. Gut 1995;36:927-930
117. Sood S, Gow PJ, Christie JM, Angus PW. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology 2004;127: 470-475
118. Witt-Sullivan H, Heathcote J, Cauch K, et al. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology 1990;12:98-105
119. He XS, Ansari AA, Gershwin ME. Xenobiotic considerations for the development of autoimmune liver diseases: bad genes and bad luck. Rev Environ Health 2001;16:191-202
120. Johnston DE, Kaplan MM, Miller KB, et al. Histocompatibility antigens in primary biliary cirrhosis. Am J Gastroenterol 1987;82:1127-1129
121. Prochazka EJ, Terasaki PI, Park MS, et al. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 1990;322:1842-1844
122. Underhill J, Donaldson P, Bray G, et al. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology 1992;16:1404-1408
123. Underhill JA, Donaldson PT, Doherty DG, et al. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 1995;21:959-962
124. Graham AM, Dollinger MM, Howie SE, Harrison DJ. Identification of novel alleles at a polymorphic microsatellite repeat region in the human NRAMP1 gene promoter: analysis of allele frequencies in primary biliary cirrhosis. J Med Genet 2000;37:150-152
125. Zappala F, Grove J, Watt FE, et al. No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis. J Hepatol 1998;28:820-823